PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 176 filers reported holding PDL BIOPHARMA INC in Q1 2018. The put-call ratio across all filers is 1.67 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $53,000 | +8.2% | 16,713 | +0.0% | 0.00% | – |
| Q2 2020 | $49,000 | -71.5% | 16,709 | -72.6% | 0.00% | – |
| Q1 2020 | $172,000 | -25.2% | 60,923 | -14.1% | 0.00% | – |
| Q4 2019 | $230,000 | -95.8% | 70,926 | -97.2% | 0.00% | -100.0% |
| Q3 2019 | $5,462,000 | -45.0% | 2,528,693 | -20.1% | 0.00% | -50.0% |
| Q2 2019 | $9,935,000 | -13.7% | 3,164,073 | +2.2% | 0.00% | -20.0% |
| Q1 2019 | $11,514,000 | +36.2% | 3,095,142 | +6.2% | 0.01% | +25.0% |
| Q4 2018 | $8,454,000 | +10.2% | 2,915,660 | -0.1% | 0.00% | +33.3% |
| Q3 2018 | $7,672,000 | +12.5% | 2,917,493 | +0.1% | 0.00% | 0.0% |
| Q2 2018 | $6,819,000 | -16.2% | 2,914,186 | +5.3% | 0.00% | -25.0% |
| Q1 2018 | $8,135,000 | +5.6% | 2,767,162 | -1.6% | 0.00% | +33.3% |
| Q4 2017 | $7,706,000 | -30.3% | 2,811,842 | -13.8% | 0.00% | -40.0% |
| Q3 2017 | $11,063,000 | +31.4% | 3,263,385 | -4.3% | 0.01% | +25.0% |
| Q2 2017 | $8,421,000 | +6.8% | 3,409,353 | -1.9% | 0.00% | 0.0% |
| Q1 2017 | $7,886,000 | +1964.4% | 3,473,956 | +1823.9% | 0.00% | – |
| Q4 2016 | $382,000 | -58.7% | 180,570 | -34.5% | 0.00% | -100.0% |
| Q3 2016 | $925,000 | +1.6% | 275,882 | -4.7% | 0.00% | 0.0% |
| Q2 2016 | $910,000 | +0.8% | 289,354 | +6.7% | 0.00% | 0.0% |
| Q1 2016 | $903,000 | -14.2% | 271,301 | -8.7% | 0.00% | 0.0% |
| Q4 2015 | $1,052,000 | -73.2% | 297,173 | -61.9% | 0.00% | -66.7% |
| Q3 2015 | $3,919,000 | -26.3% | 779,125 | -5.8% | 0.00% | -25.0% |
| Q2 2015 | $5,316,000 | -18.3% | 826,711 | -10.6% | 0.00% | -20.0% |
| Q1 2015 | $6,507,000 | -63.1% | 924,805 | -59.5% | 0.01% | -54.5% |
| Q4 2014 | $17,617,000 | +26.5% | 2,284,894 | +22.6% | 0.01% | +10.0% |
| Q3 2014 | $13,927,000 | -37.0% | 1,864,394 | -18.4% | 0.01% | -33.3% |
| Q2 2014 | $22,114,000 | +111.7% | 2,284,485 | +81.7% | 0.02% | +87.5% |
| Q1 2014 | $10,448,000 | +28.0% | 1,257,272 | +30.0% | 0.01% | +33.3% |
| Q4 2013 | $8,162,000 | +23.9% | 967,016 | +17.0% | 0.01% | +20.0% |
| Q3 2013 | $6,585,000 | +4.3% | 826,221 | +1.0% | 0.01% | 0.0% |
| Q2 2013 | $6,316,000 | – | 818,075 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nine Chapters Capital Management LLC | 119,700 | $254,000 | 0.43% |
| GSA CAPITAL PARTNERS LLP | 1,587,756 | $3,366,000 | 0.20% |
| AMERICAFIRST CAPITAL MANAGEMENT, LLC | 60,901 | $129,110,000 | 0.14% |
| Acrospire Investment Management LLC | 129,480 | $274,000 | 0.11% |
| SECOR Capital Advisors, LP | 410,323 | $870,000 | 0.11% |
| RBF Capital, LLC | 251,421 | $540,000 | 0.08% |
| Park West Asset Management LLC | 400,000 | $848,000 | 0.07% |
| MACKENZIE FINANCIAL CORP | 4,687,825 | $9,938,000 | 0.06% |
| CIGNA INVESTMENTS INC /NEW | 261,533 | $554,000,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 5,503,285 | $11,665,000 | 0.06% |